Author:
Mizuno Shinya,Osaki Eriko
Publisher
Springer International Publishing
Reference72 articles.
1. Ramachandran P, Henderson NC. Antifibrotics in chronic liver disease: tractable targets and translational challenges. Lancet Gastroenterol Hepatol. 2016;1:328–40.
2. Kubo N, Araki K, Kuwano H, et al. Cancer-associated fibroblasts in hepatocellular carcinoma. World J Gastroenterol. 2016;22:6841–50.
3. Dooley S, ten Dijke P. TGF-β in progression of liver disease. Cell Tissue Res. 2012;347:245–56.
4. Annoni G, Weiner FR, Zern MA. Increased transforming growth factor-β1 gene expression in human liver disease. J Hepatol. 1992;14:259–64.
5. Kanzler S, Lohse AW, Keil A, et al. TGF-β1 in liver fibrosis: an inducible transgenic mouse model to study liver fibrogenesis. Am J Phys. 1999;276:G1059–68.